Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
The Motley Fool February 2, 2010 Brian Orelli	Shaking Up the Biotech Industry A judge will decide if genes are patentable or not.
Information Today December 10, 2013	EBSCO Discovery Service Integrates Full-Text Patents EBSCO Information Services added content from the United States Patent and Trademark Office to EBSCO Discovery Service.
IEEE Spectrum February 2006 Lee A. Hollaar	Patents 2.0 There are big problems with patents, especially software patents. A new type of patent is needed -- Congress should create a new, limited protection that protects against knockoffs without overreaching.
Chemistry World September 12, 2012 Jon Evans	Drawing maps to hunt for biological gold Pharmaceutical companies should pay more attention to traditional medicine, say UK researchers. This follows their discovery that genetically-similar plants have traditionally been used to treat the same conditions in widely separated parts of the world.
The Motley Fool April 22, 2011 Sean Williams	Pharma's Most Perilous Pipelines Patent expirations expose weaknesses for these Wall Street darlings.
Chemistry World June 28, 2007 Hepeng Jia	First Internationally Licensed Chinese Herbal Patent China has licensed its first herbal compound patent to an overseas pharmaceutical company.
Chemistry World April 2011	Molecular Obesity is Weighing Down Drug Discovery Medicinal chemistry's quest for potent drug candidates has resulted in molecules that are too large and too lipophilic for their own good.
Chemistry World October 2006	Head to Head For: Patents protect inventions by giving the owner of the patent the right to stop anyone from making or using the invention without the owner's permission... Against: Patents are a menace...
Pharmaceutical Executive September 1, 2010	Looking Beyond the Patent Cliff Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP.
CIO January 1, 2003 Christopher Koch	Patently Stupid? It's not clear at the start of 2003 whether the software patent frenzy will cause innovation to flower or be trampled.
Bio-IT World November 12, 2002 Andrew W. Torrance	After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large.
Chemistry World November 28, 2008 Matt Wilkinson	EU claims pharma delaying tactics cost 3 billion euros Pharmaceutical manufacturers have been criticised by the EU competition commission for slowing the entry of generic medicines to the market.
Inc. July 24, 2002 Jennifer A. Redmond	Strategic Patenting What to consider when you're filing a patent and strategic decisions you'll need to make.
Knowledge@Wharton	Drug Companies and the Patent Game: Fair Play or Foul? Is legal maneuvering a legitimate attempt by the big pharmaceutical companies to recover the huge costs of developing new drugs? Or are the brand-name firms inappropriately gaming the system for their own benefit, to the detriment of consumers and insurance companies?
IndustryWeek August 1, 2006	Patents: Eleven Issues To Consider... How patent savvy are you?
Bio-IT World November 2005 Patrick R. Scanlon	Patent Term Extension Primer U.S. patent law includes provisions for extending the patent term of medical devices and pharmaceuticals in instances when lengthy FDA approval is taking place during the term.
Chemistry World June 23, 2010 Sarah Houlton	A smaller future for big pharma? Cutting the amount spent on medicines may be an easy way for governments to help balance the books in the short term, but in the long run it will impact the ability to discover new medicines.
AskMen.com March 19, 2003 Steve Richer	How To: Patent An Invention Investors will not do business with you until you have that precious little number that guarantees that you own the rights to the invention. Read on to see how you can obtain a patent.
Information Today July 6, 2010 George H. Pike	Supreme Court Confirms Patentability of Business Methods, Denies Bilski Patent The lengthy and complex decision, entitled Bilski v. Kappos, affirmed the legality of business method patents, while leaving unanswered some questions about the scope and breadth of such patents.
Pharmaceutical Executive May 1, 2005 Margaret Buck	Legal: No Exception? An important legal loophole has made patented tools available for biotech research. Today, though, it appears to be closing.
HBS Working Knowledge April 21, 2014 Carmen Nobel	Bio-piracy: When Western Firms Usurp Eastern Medicine Raj Choudhury and Tarun Khanna examine the history of herbal patent applications, challenging a stereotype that characterizes Western firms as innovators and emerging markets as imitators.
The Motley Fool November 1, 2004 Brian Gorman	Bristol-Myers Stays the Course The pharma remains downbeat on its outlook through 2006, but two promising compounds could lift the company's fortunes.
Linux Journal January 1, 2007 Jon Hall	Beachhead - Ode to Joy Thoughts on the purpose of patents, the problems with software patents, and how patents impacted the piano.
Pharmaceutical Executive August 1, 2005 Jill Wechsler	Washington Report: Treating Patents It may seem unusual that a court ruling challenging patent protections is considered a victory for Big Pharma. But the decision was supported by pharmaceutical companies, along with the Justice Department, as a way to spur biomedical research and new-drug development.
InternetNews November 24, 2004 Jim Wagner	Nick Godici, Commissioner for Patents, USPTO The U.S. Patent & Trademark Office has been taking a lot of heat in recent years over software patents. Sitting at the center of the firestorm, and the patent process, is Nick Godici, the agency's Commissioner for Patents.
Chemistry World April 8, 2013 Philip Robinson	The truth about snake oil? US scientists have carried out the first analyses of old 'patent medicines' - medicinal preparations from the turn of the last century - to identify the chemical constituents of the medications and perhaps determine if there was any truth in the wild health claims they made.
Chemistry World April 8, 2013 Sarah Houlton	India rejects Novartis patent appeal India's Supreme Court has denied Novartis' appeal against the decision to refuse patent protection for its anticancer drug Glivec (imatinib mesylate).
IEEE Spectrum April 2006 Hugh Loebner	Do-It-Yourself Patents Drafting a patent application is challenging, but for those with an engineering turn of mind, it's also a great deal of fun. Inventors, take note.
Information Today May 2004 George H. Pike	You Can't Do That, It's Patented There are an increasing number of questionable patent claims that cover Internet technologies and techniques, and permission must be obtained for their use.
CIO August 1, 2003 Mark Radcliffe	Patents: A Small Price to Pay for Progress For CIOs, the issue is not whether patents should be granted for software but whether anything can be done to improve the quality of the granted patents. The problem relates more to the examining process in the USPTO than to the appropriateness of patents for software.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
Inc. June 2006 Athena Schindelheim	Great Moments In Patent History With the blockbuster BlackBerry settlement and a case involving eBay before the Supreme Court, the dowdy world of patent law is suddenly hot.
Chemistry World January 26, 2009 Jia & Yuan	China pushes for higher quality patents In an effort to boost the quality of patent applications, and encourage Chinese firms to obtain international patents, China has revised its patent law.
Bio-IT World June 17, 2004 Cathryn Campbell	Patent Plaintiff Perils Suing for patent infringement may seem rewarding, but you could lose even more.
Chemistry World June 2010	Column: In the pipeline Derek Lowe looks into his crystal ball to see what the future of medicinal chemistry might be
InternetNews May 20, 2005 Sean Michael Kerner	A Primer on Software Patents A closer look at software patents and at their history and implications for IT.
Chemistry World January 7, 2013 Laura Howes	Digging up ancient drug formulations Some of the medicines we take today, such as aspirin, have a long history. But analysis of drugs found in an ancient shipwreck that sank in the second century BC threw up some compounds that are still being used by the medical profession today.
IEEE Spectrum December 2007 Kirk Teska	The Foreign Patent Money Trap You may well need patents in many countries, but that doesn't mean you can afford them.
Chemistry World July 10, 2013 Darren Smyth	How to invent and protect your invention Even as an account of US patent law, this book, by Kennedy et al., has little to commend it. It is difficult to understand in many places, the selection of topics for coverage is peculiar, and is downright wrong in many details.
The Motley Fool September 12, 2005 M.D. Mitchell	Big Problems for Big Pharma Creating new drugs is never easy, but the companies that excel in three key areas are the ones for investors to watch.
Pharmaceutical Executive June 1, 2005 Peter J. Pitts	Opinion: Uncle Sam, MD Is having the government pursue a patent the best way of placing important discoveries in the public domain? It depends. Is putting the government in control of drug development in the best interests of public health? No.
The Motley Fool December 29, 2006 Brian Lawler	Lilly's Patents Stay in Bloom Even with upcoming patent expiries, Lilly isn't in nearly the same desperate situation that some of its large-cap pharma peers will be dealing with in the upcoming years. Investors, take note.
The Motley Fool October 3, 2007 Rich Duprey	No Patents on Thinking ... Yet Over the years, the U.S. Patent office has patented a few too many ideas. The Supreme Court is now spending more time deciding whether a company has really infringed on a patent, rather than automatically issuing an infringement.
The Motley Fool October 14, 2010 Sean Williams	Should You Let AstraZeneca Go? Multiple drug patent expirations await. It's time to run away.
Chemistry World May 2007 Lisa Melton	Chinese Medicine in Western Packaging The past decade has seen a global awakening to the truly curative powers of many ancient medicines, from black bear bile to the Asian plant Epimedium.
The Motley Fool June 15, 2005 Brian Gorman	Patented Drugs Fair Game in R&D The Supreme Court's ruling could be bad news for investors in small pharma and biotech.
InternetNews September 1, 2006 Susan Kuchinskas	Patents Become a 'Social' Problem Social media - photos, blogs, networks and tags - is all about sharing. But social media startups don't want to share their intellectual property. Instead, they're heading to the patent office.
Salon.com April 24, 2000 Mark Compton	Lean, green gene-counting machine Incyte CEO Roy Whitfield gives biotech investors and patent critics a few lessons on genomic research.
InternetNews December 10, 2008 Sean Michael Kerner	Will Linux Defenders Save Linux from Microsoft? New legal initiative is designed to ensure quality patents and get rid of bad ones.